UniProt ID | SYEM_HUMAN | |
---|---|---|
UniProt AC | Q5JPH6 | |
Protein Name | Probable glutamate--tRNA ligase, mitochondrial | |
Gene Name | EARS2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 523 | |
Subcellular Localization | Mitochondrion matrix. | |
Protein Description | Catalyzes the attachment of glutamate to tRNA(Glu) in a two-step reaction: glutamate is first activated by ATP to form Glu-AMP and then transferred to the acceptor end of tRNA(Glu).. | |
Protein Sequence | MAALLRRLLQRERPSAASGRPVGRREANLGTDAGVAVRVRFAPSPTGFLHLGGLRTALYNYIFAKKYQGSFILRLEDTDQTRVVPGAAENIEDMLEWAGIPPDESPRRGGPAGPYQQSQRLELYAQATEALLKTGAAYPCFCSPQRLELLKKEALRNHQTPRYDNRCRNMSQEQVAQKLAKDPKPAIRFRLEQVVPAFQDLVYGWNRHEVASVEGDPVIMKSDGFPTYHLACVVDDHHMGISHVLRGSEWLVSTAKHLLLYQALGWQPPHFAHLPLLLNRDGSKLSKRQGDVFLEHFAADGFLPDSLLDIITNCGSGFAENQMGRTLPELITQFNLTQVTCHSALLDLEKLPEFNRLHLQRLVSNESQRRQLVGKLQVLVEEAFGCQLQNRDVLNPVYVERILLLRQGHICRLQDLVSPVYSYLWTRPAVGRAQLDAISEKVDVIAKRVLGLLERSSMSLTQDMLNGELKKLSEGLEGTKYSNVMKLLRMALSGQQQGPPVAEMMLALGPKEVRERIQKVVSS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
44 | Phosphorylation | VRVRFAPSPTGFLHL EEEEECCCCCCCEEC | 31.50 | 20068231 | |
46 | Phosphorylation | VRFAPSPTGFLHLGG EEECCCCCCCEECCH | 44.92 | 20068231 | |
56 | Phosphorylation | LHLGGLRTALYNYIF EECCHHHHHHHHHHH | 26.51 | 18452278 | |
59 | Phosphorylation | GGLRTALYNYIFAKK CHHHHHHHHHHHCHH | 11.94 | 18452278 | |
61 | Phosphorylation | LRTALYNYIFAKKYQ HHHHHHHHHHCHHCC | 5.48 | 18452278 | |
67 | Phosphorylation | NYIFAKKYQGSFILR HHHHCHHCCCEEEEE | 19.87 | 22210691 | |
91 | Ubiquitination | VPGAAENIEDMLEWA CCCHHHCHHHHHHHC | 3.41 | 24816145 | |
108 | Methylation | PPDESPRRGGPAGPY CCCCCCCCCCCCCCC | 58.78 | - | |
134 | Phosphorylation | ATEALLKTGAAYPCF HHHHHHHCCCCCCCC | 31.83 | 26074081 | |
138 | Phosphorylation | LLKTGAAYPCFCSPQ HHHCCCCCCCCCCHH | 10.45 | 26074081 | |
143 | Phosphorylation | AAYPCFCSPQRLELL CCCCCCCCHHHHHHH | 12.10 | 25159151 | |
160 | Ubiquitination | EALRNHQTPRYDNRC HHHHCCCCCCCCHHH | 11.37 | 24816145 | |
178 | Ubiquitination | SQEQVAQKLAKDPKP CHHHHHHHHHCCCCH | 40.45 | 29967540 | |
178 | Acetylation | SQEQVAQKLAKDPKP CHHHHHHHHHCCCCH | 40.45 | 25953088 | |
184 | Ubiquitination | QKLAKDPKPAIRFRL HHHHCCCCHHHHHHH | 58.16 | 24816145 | |
256 | Succinylation | EWLVSTAKHLLLYQA HHHHHHHHHHHHHHH | 34.57 | - | |
256 | Succinylation | EWLVSTAKHLLLYQA HHHHHHHHHHHHHHH | 34.57 | - | |
326 | Phosphorylation | AENQMGRTLPELITQ HHCCHHCCHHHHHHH | 40.72 | 24043423 | |
332 | Phosphorylation | RTLPELITQFNLTQV CCHHHHHHHCCCCCC | 39.47 | 24043423 | |
337 | Phosphorylation | LITQFNLTQVTCHSA HHHHCCCCCCCCCHH | 23.30 | 24043423 | |
340 | Phosphorylation | QFNLTQVTCHSALLD HCCCCCCCCCHHHHC | 8.49 | 24043423 | |
343 | Phosphorylation | LTQVTCHSALLDLEK CCCCCCCHHHHCHHH | 23.82 | 24043423 | |
387 | Ubiquitination | VEEAFGCQLQNRDVL HHHHHCCCCCCCCCC | 46.60 | 21890473 | |
393 | Ubiquitination | CQLQNRDVLNPVYVE CCCCCCCCCCHHHHH | 5.13 | 23503661 | |
398 | Phosphorylation | RDVLNPVYVERILLL CCCCCHHHHHHHHHH | 9.61 | - | |
447 | 2-Hydroxyisobutyrylation | EKVDVIAKRVLGLLE HHHHHHHHHHHHHHH | 31.73 | - | |
447 | Acetylation | EKVDVIAKRVLGLLE HHHHHHHHHHHHHHH | 31.73 | 25953088 | |
456 | Ubiquitination | VLGLLERSSMSLTQD HHHHHHHHCCCHHHH | 22.48 | 21890473 | |
462 | Ubiquitination | RSSMSLTQDMLNGEL HHCCCHHHHHHHHHH | 39.13 | 23503661 | |
470 | Ubiquitination | DMLNGELKKLSEGLE HHHHHHHHHHHHCCC | 47.57 | - | |
470 | Acetylation | DMLNGELKKLSEGLE HHHHHHHHHHHHCCC | 47.57 | 19809829 | |
473 | Phosphorylation | NGELKKLSEGLEGTK HHHHHHHHHCCCCCH | 38.20 | 22985185 | |
480 | Ubiquitination | SEGLEGTKYSNVMKL HHCCCCCHHHHHHHH | 58.50 | 21890473 | |
480 | Malonylation | SEGLEGTKYSNVMKL HHCCCCCHHHHHHHH | 58.50 | 26320211 | |
486 | Malonylation | TKYSNVMKLLRMALS CHHHHHHHHHHHHHC | 39.84 | 26320211 | |
486 | Ubiquitination | TKYSNVMKLLRMALS CHHHHHHHHHHHHHC | 39.84 | 23503661 | |
486 | Acetylation | TKYSNVMKLLRMALS CHHHHHHHHHHHHHC | 39.84 | 19608861 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SYEM_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SYEM_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SYEM_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of SYEM_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
614924 | Combined oxidative phosphorylation deficiency 12 (COXPD12) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-486, AND MASS SPECTROMETRY. |